| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 6e-05 |